Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone

The survival benefits of conversion surgery in patients with metastatic gastric cancer (mGC) remain unclear. Thus, this study aimed to determine the outcomes of conversion surgery compared to in-front surgery plus palliative chemotherapy (PCT) or in-front surgery alone for mGC. We recruited 182 cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ruo-Yi, Kou, Hao-Wei, Le, Puo-Hsien, Kuo, Chia-Jung, Chen, Tsung-Hsing, Wang, Shang-Yu, Chen, Jen-Shi, Yeh, Ta-Sen, Hsu, Jun-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026725/
https://www.ncbi.nlm.nih.gov/pubmed/35455672
http://dx.doi.org/10.3390/jpm12040555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026725/
https://www.ncbi.nlm.nih.gov/pubmed/35455672
http://dx.doi.org/10.3390/jpm12040555

Ejemplares similares